p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway

Slides:



Advertisements
Similar presentations
Volume 13, Issue 2, Pages (February 2011)
Advertisements

Volume 16, Issue 6, Pages (August 2016)
Volume 43, Issue 1, Pages (July 2011)
Volume 68, Issue 1, Pages e6 (October 2017)
MCRS1 Binds and Couples Rheb to Amino Acid-Dependent mTORC1 Activation
mTORC1 regulates TFEB. (A) Lysosomal stress inhibits mTOR signalling.
Volume 11, Issue 4, Pages (April 2003)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 33, Issue 2, Pages (January 2009)
Volume 3, Issue 3, Pages (March 2006)
Teruaki Fujishita, Masahiro Aoki, Makoto M. Taketo  Gastroenterology 
Volume 57, Issue 3, Pages (February 2015)
Volume 28, Issue 3, Pages (September 2015)
Volume 12, Issue 8, Pages (August 2015)
Volume 134, Issue 2, Pages (July 2008)
A New Link in the Chain from Amino Acids to mTORC1 Activation
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Volume 13, Issue 2, Pages (February 2011)
Volume 52, Issue 4, Pages (November 2013)
Volume 9, Issue 1, Pages 1-8 (October 2014)
Volume 45, Issue 5, Pages (March 2012)
Volume 137, Issue 5, Pages (May 2009)
Volume 68, Issue 2, Pages e6 (October 2017)
Volume 67, Issue 6, Pages e7 (September 2017)
Volume 45, Issue 2, Pages (January 2012)
Volume 29, Issue 3, Pages (May 2014)
Volume 29, Issue 5, Pages (March 2008)
Sestrins Inhibit mTORC1 Kinase Activation through the GATOR Complex
SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
Volume 46, Issue 6, Pages (June 2012)
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Volume 66, Issue 4, Pages e5 (May 2017)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 47, Issue 1, Pages (July 2012)
Volume 45, Issue 6, Pages (March 2012)
PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD, leading to mTORC2 activation. PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD,
Volume 56, Issue 5, Pages (December 2014)
Volume 10, Issue 5, Pages (February 2015)
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Glutaminolysis Activates Rag-mTORC1 Signaling
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway
Volume 50, Issue 2, Pages (April 2013)
Volume 58, Issue 5, Pages (June 2015)
Volume 49, Issue 1, Pages (January 2013)
Volume 36, Issue 2, Pages (October 2009)
Volume 13, Issue 4, Pages (April 2008)
Volume 171, Issue 3, Pages e12 (October 2017)
Volume 52, Issue 2, Pages (October 2013)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Volume 57, Issue 6, Pages (March 2015)
Volume 18, Issue 4, Pages (April 2010)
Disruption of the Rag-Ragulator Complex by c17orf59 Inhibits mTORC1
Volume 49, Issue 6, Pages (March 2013)
Fan Yang, Huafeng Zhang, Yide Mei, Mian Wu  Molecular Cell 
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Leucine Signals to mTORC1 via Its Metabolite Acetyl-Coenzyme A
Volume 34, Issue 6, Pages (June 2009)
Volume 58, Issue 6, Pages (June 2015)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Volume 4, Issue 4, Pages (October 1999)
Volume 49, Issue 1, Pages (January 2013)
Volume 16, Issue 5, Pages (May 2009)
Phosphorylation and Functional Inactivation of TSC2 by Erk
Volume 57, Issue 2, Pages (January 2015)
Volume 11, Issue 5, Pages (May 2010)
Volume 65, Issue 5, Pages e4 (March 2017)
Volume 3, Issue 3, Pages (March 2006)
Volume 58, Issue 3, Pages (May 2015)
Volume 9, Issue 2, Pages (October 2014)
Presentation transcript:

p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway Angeles Duran, Ramars Amanchy, Juan F. Linares, Jayashree Joshi, Shadi Abu-Baker, Aleksey Porollo, Malene Hansen, Jorge Moscat, Maria T. Diaz-Meco  Molecular Cell  Volume 44, Issue 1, Pages 134-146 (October 2011) DOI: 10.1016/j.molcel.2011.06.038 Copyright © 2011 Elsevier Inc. Terms and Conditions

Molecular Cell 2011 44, 134-146DOI: (10.1016/j.molcel.2011.06.038) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 p62 Interacts with Raptor and Components of the mTORC1 Complex, but Not of mTORC2 (A) LC-MS/MS spectra of the purified Flag-p62 peptides corresponding to raptor from NIH 3T3 cells stably expressing Flag-p62. (B) Lysates and Flag immunoprecipitates from NIH 3T3 and 293 cells stably expressing Flag-p62 were analyzed to detect the indicated proteins. (C–G) 293 cells were transfected with the indicated complementary DNAs (cDNAs) in expression vectors, cell lysates were prepared, and lysates and HA-, Flag-, or myc-tagged immunoprecipitates were analyzed by immunoblotting to quantify the specified ectopic proteins. (H) Endogenous interaction of p62 with components of the mTOR signaling pathway in response to amino acids or leucine. Cell lysates and p62 immunoprecipitates from amino acid- or leucine-treated HEK293T cells were analyzed for the levels of specified proteins. These results are representative of three experiments. See also Figure S1. Molecular Cell 2011 44, 134-146DOI: (10.1016/j.molcel.2011.06.038) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 p62 Is Essential for mTORC1 Activation in Response to Amino Acids (A and B) Effects of p62 depletion on activation of the mTORC1 pathway in response to amino acids (A) or insulin (B). p62fl/fl MEFs were infected with GFP or CRE adenoviruses and were then stimulated with amino acids or insulin. Lysates were analyzed for levels of the specified proteins. (C) WT and p62KO MEFs, reconstituted with p62FL or p62CT, were treated as described in (A). Cell lysates were prepared and analyzed by immunoblotting for the levels of the indicated proteins. (D) 293 cells stably expressing Flag-p62 were deprived of amino acids and serum for 50 min, pretreated with rapamycin for 30 min, and then stimulated with amino acids for the indicated durations. Cell lysates were analyzed for the levels of the specified proteins. These results are representative of three experiments. See also Figure S2. Molecular Cell 2011 44, 134-146DOI: (10.1016/j.molcel.2011.06.038) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 p62 Regulates Cell Size and Autophagy (A) Cell size was determined in WT and p62KO MEFs deprived of leucine for 24 hr and restimulated with leucine for 24 hr. Error bars specify the standard deviation between three independently performed experiments. ∗p < 0.05. (B) WT and p62KO MEFs were deprived of leucine and serum for 2 and 4 hr in the absence or presence NH4Cl and leupeptin. Cell lysates were analyzed for the levels of the specified proteins. Graphs represent the densitometric LC3-II/actin ratios. (C) Protein extracts from livers of 24 hr fasted WT and p62KO mice were analyzed for the levels of the specified proteins. These results are representative of three experiments. See also Figure S3. Molecular Cell 2011 44, 134-146DOI: (10.1016/j.molcel.2011.06.038) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Amino Acid-Induced Regulation of the p62-Rag Complex (A) Cell lysates and Flag-p62 immunoprecipitates from NIH 3T3 cells stably expressing Flag-p62 were analyzed by immunoblotting to determine levels of the specified proteins. (B) p62 preferentially binds to RagC. 293 cells were transfected with the indicated cDNAs in expression vectors, cell lysates were prepared, and lysates and HA- or Flag-tagged immunoprecipitates were analyzed by immunoblotting to determine amounts of the specified ectopic proteins. (C) Endogenous interaction of p62 with Rags and components of Ragulator in response to amino acids. Cell lysates and p62 immunoprecipitates from amino acid-treated 293 cells were analyzed for the levels of specified proteins. (D–G) 293 cells were transfected with the indicated cDNAs in expression vectors, cell lysates were prepared, and lysates and HA- or Flag-tagged immunoprecipitates were analyzed by immunoblotting to determine amounts of the specified ectopic proteins. (H) Recombinant MBP-p62 was incubated with HA-raptor purified from HEK293T cells, and the ability of raptor to bind directly to p62 was determined in pull-down experiments employing HA beads. (I) In vitro-translated RagC was incubated with MBP or MBP-p62, and its ability to bind directly to p62 was determined in pull-down experiments employing amylose beads. (J) Recombinant MBP-p62 was incubated with HA-raptor purified from HEK293T cells, in the absence or presence of RagBGTP and RagCGDP, and the ability of raptor to bind directly to p62 was determined in pull-down experiments employing HA beads. These results are representative of three experiments. Molecular Cell 2011 44, 134-146DOI: (10.1016/j.molcel.2011.06.038) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 5 p62 Promotes Formation of the Active Rag Heterodimer (A) p62 stabilizes the Rag heterodimer. HEK293T cells were transfected with the indicated cDNAs in expression vectors, cell lysates were prepared, and lysates and Flag-tagged immunoprecipitates were analyzed by immunoblotting to detect the specified ectopic proteins. The graph shows a quantification of the RagB/C dimer formation. Results are represented as means ± standard deviations of three different experiments. ∗p < 0.05. (B) p62 immunoprecipitates from 293 cells, infected with lentiviral shRNA for RagC and RagD, or nontargeting (NT) shRNA, were analyzed by immunoblotting to determine levels of the specified proteins. (C) Cell lysates and RagC immunoprecipitates from WT and p62 KO immortal MEFs reconstituted with p62FL or p62CT were analyzed by immunoblotting to determine levels of specified proteins. (D) Effects of p62 on GTP loading of RagB. The percentage of GTP bound to RagB is indicated for each sample. A portion of cell lysate was taken before immunoprecipitation to probe for expression. (E) p62fl/fl MEFs, infected with GFP or CRE adenovirus, were transfected with Flag-RagBGTP and RagCGDP. Cells were starved for 4 hr and restimulated with amino acids for 10 min. Cell lysates were analyzed by immunoblotting to determine levels of the specified proteins. These results are representative of three experiments. See also Figure S4. Molecular Cell 2011 44, 134-146DOI: (10.1016/j.molcel.2011.06.038) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 6 p62 Regulates mTOR Translocation to the Lysosomal Compartment (A–D) Starved or restimulated 293 cells were co-immunostained for p62 and LAMP2 (A), RagC (B), mTOR (C), or raptor (D). (E) p62fl/fl MEFs infected with GFP or CRE adenovirus and overexpressing activated RagB were starved for 4 hr and then restimulated with amino acids for 10 min. Afterward, they were coimmunostained for mTOR and LAMP2. (F) Images of WT and p62 KO immortal MEFs coimmunostained for RagC and LAMP2. In all images, inserts show selected fields that were magnified two or five times to show areas of staining overlap (Merge). Scale bars represent 10 μm. Images are representative of three experiments. See also Figure S5. Molecular Cell 2011 44, 134-146DOI: (10.1016/j.molcel.2011.06.038) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 7 p62 Drives Tumorigenesis through Activation of the mTORC1 Pathway (A) Positive correlation between p62 and S6K1 mRNA levels in human cancers. (B) Cap2 cells were infected with lentiviral shRNAs, including nontargeting shRNA (shNT) and two different lentiviral shRNAs for p62 (shp62#1 and shp62#2). After selection with puromycin, levels of p62 were analyzed by immunoblot. (C and D) Growth curve of shNT and shp62 cells under normal growing conditions (C) or in the absence of serum (D). Results are shown as means ± standard deviations. (E) Soft-agar growth of shNT and shp62 Cap2 cells, and quantification of the number of colonies at 21 days. The experiment shown is representative of another two with similar results. The graph shows means ± standard deviations. (F) Suspensions of shNT and shp62 Cap2 cells, as described in (B), were intradermally injected into each flank of nude mice, and tumors were allowed to develop for 15 days. Tumor size was measured twice per week. Results are shown as means ± standard deviations (n = 5). (G) Immunohistochemical analysis of Ki67 expression in shNT and shp62 Cap2 cell xenografts (left). The graph shows the quantitation of Ki67-positive cells in these tumors (right). Results are shown as the means ± standard deviations of counts from ten different fields per mouse, with a total of five mice per condition. (H) Cell lysates from these tumors (X1 and X2) were analyzed by immunoblotting to determine amounts of the specified proteins. (I) Stably expressing Flag-RagBGTP or Flag-Rheb prostate cancer cells were infected with shNT or shp62 lentiviral vectors. Cell lysates were analyzed by immunoblotting to determine levels of specified proteins (left). Cell viability was determined at 3 days after serum withdrawal (right). Results are shown as means ± standard deviations. (J) Stably expressing Flag-p62 cells were analyzed by immunoblotting to determine levels of the specified proteins (left). Cell viability was determined at 3 days after serum withdrawal (right) in the presence or absence of rapamycin. Results are shown as means ± standard deviations. (K) Model for the role of p62 in amino acid signaling toward mTORC1 activation. See also Figure S6. Molecular Cell 2011 44, 134-146DOI: (10.1016/j.molcel.2011.06.038) Copyright © 2011 Elsevier Inc. Terms and Conditions